Trial intelligence / Profile preview

Efficacy and Safety of PBK_M2101 for Colon Cleansing

NCT05923918Phase 3Unknown

Sponsor
Pharmbio Korea Inc.
Start
Jun 2023
Primary completion
May 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of PBK_M2101, sponsored by Pharmbio Korea Inc.. Status: unknown.

02

Drugs

PBK_M2101

Beyond the preview

Go deeper on NCT05923918.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05923918.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call